AISAP Cardio vs Zio ECG Utilization Software (ZEUS) System
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if your clinical setting requires immediate, bedside cardiac diagnostic assessments for early detection of structural heart disease or heart failure. This tool is ideal for rapidly obtaining comprehensive measurements of valvular pathologies, Left Ventricle Ejection Fraction (LVEF), and cardiac dimensions directly at the point of care, integrating seamlessly into existing POCUS workflows.
View AISAP Cardio →Choose Zio ECG Utilization Software (ZEUS) System if…
Choose the Zio ECG Utilization Software (ZEUS) System if you need to monitor patients for cardiac arrhythmias over an extended period, up to 14 days, using a wearable biosensor. This platform is best suited for identifying and classifying intermittent arrhythmias through continuous ECG data analysis, providing comprehensive reports for remote diagnosis and management.
View Zio ECG Utilization Software (ZEUS) System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | Zio ECG Utilization Software (ZEUS) System |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based | Cloud-based (AWS EC2 platform) |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools are designed for ease of use within their respective clinical contexts. AISAP Cardio focuses on rapid, automated assessments at the point of care, integrating with existing workflows. ZEUS offers a web portal and mobile application for healthcare professionals, streamlining the review of continuous ECG data and providing comprehensive reports.
Clinical Value
TieBoth AISAP Cardio and ZEUS are FDA-cleared and provide significant clinical value in different areas of cardiology. AISAP Cardio excels in the early detection of structural heart disease and heart failure through comprehensive POCUS assessments. ZEUS specializes in diagnosing and managing cardiac arrhythmias through continuous ECG monitoring with proprietary deep-learned algorithms.
Pricing & Value
TieNeither company provides public pricing information for their tools, making it impossible to conduct a head-to-head comparison on this dimension. Both require direct contact for demo and pricing details.
Enterprise Readiness
Zio ECG Utilization Software (ZEUS) SystemTool B (ZEUS) explicitly states HIPAA compliance and implies the use of Business Associate Agreements (BAAs) in its structured facts, leveraging a known cloud platform (AWS EC2). While Tool A (AISAP Cardio) mentions HIPAA compliance and integration with EHR/EMR/PACS, Tool B's explicit compliance statements and established cloud infrastructure demonstrate a slightly higher degree of enterprise readiness.
Innovation
Zio ECG Utilization Software (ZEUS) SystemWhile AISAP Cardio's AI-powered POCUS for rapid, bedside cardiac assessments is highly innovative, ZEUS demonstrates a broader innovation by integrating AI with wearable biosensors for continuous, long-term ECG monitoring. This combination of wearables, cloud-based analytics, and deep-learned algorithms for arrhythmia detection represents a significant advancement in remote patient monitoring.
Support & Docs
Zio ECG Utilization Software (ZEUS) SystemNeither tool explicitly details support or documentation in the initial facts. However, iRhythm Technologies (Tool B's company) is a larger, more established entity with a broader market presence, and their website indicates comprehensive support and provides access to instructions for use. This suggests a more robust support infrastructure compared to AISAP, where specific documentation is not as readily apparent from public searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | Zio ECG Utilization Software (ZEUS) System |
|---|---|---|
| Name | AISAP Cardio | Zio ECG Utilization Software (ZEUS) System |
| Company | Aisap | iRhythm Technologies |
| Description | FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. |
| Key Functionality | AI-powered interpretation for early cardiac disease detection, comprehensive cardiac ultrasound software package, automated generation of analyses, interpretations, and reports, assessment of valvular pathologies, measurement of Left Ventricle Ejection Fraction (LVEF), measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. | AI algorithm for arrhythmia detection and classification, continuous ECG data analysis (up to 14 days), cloud-based data analytics, proprietary deep-learned algorithms for enhanced diagnostic accuracy, comprehensive end-of-wear reports for physician review. |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology, Family Medicine, Internal Medicine |
| Integration | Integration with existing clinical workflows, EHR/EMR, and PACS | Integration with Zio wearable biosensors (Zio monitor, Zio Watch), HL7-based EHR integration |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and Zio ECG Utilization Software (ZEUS) System.
Frequently Asked Questions
More Comparisons
More matchups featuring AISAP Cardio or Zio ECG Utilization Software (ZEUS) System
Backers
Who funded each tool's parent company.